Advances in DNA sequence specific agents, Volume 3: a research annual
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Greenwich (Connecticut)
Jai Press
1998
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Beschreibung: | In this volume the entire focus is devoted to the macromolecule target specificity of DNA interactive developmental therapeutic agents of current interest. A brief introduction to DNA interactive anticancer agents is included for readers who may benefit from an overview surrounding the developments that have contributed to our general understanding of this field. The following nine chapters have been carefully chosen so that they describe topics which are at the forefront of development in DNA-targeted cancer chemotherapy. Issues that have been addressed include the mechanisms of selective DNA topoisomerase I and II poisoning by antitumor agents (Chapters 1 and 2), sequence-specific recognition of DNA by groove-binding drugs and drug-conjugates (Chapters 3 and 4), recent developments in nitrogen mustard alkylating agents and their potential use for antibody-directed enzyme-prodrug therapy (Chapter 5), nonclassical platinum anticancer complexes, including dinuclear and trans-platinum derivatives (Chapter 6), DNA cleaving antitumor chromoproteins containing reactive enediyne moieties, which exhibit interesting free-radical chemistry along with selective targeting (Chapter 7), the potential of new sequence-specific antisense and antigene therapy in oncology (Chapter 8), and finally the conceivable chemotherapeutic use of mimetics of the DNA structure, obtained by substitution of the sugar-phosphate natural chain with a peptide backbone, the so-called peptide nucleic acids (Chapter 9). Important approaches being currently investigated for selective cancer treatment, such as gene therapy and immunochemotherapy, are not discussed in this volume since they fall beyond its scope Bibliogr. Index |
| Beschreibung: | 1 Online-Ressource (x, 283 p.) |
| ISBN: | 9780762302031 0762302038 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV042305411 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 150129s1998 |||| o||u| ||||||eng d | ||
| 020 | |a 9780762302031 |9 978-0-7623-0203-1 | ||
| 020 | |a 0762302038 |9 0-7623-0203-8 | ||
| 035 | |a (OCoLC)162130678 | ||
| 035 | |a (DE-599)BVBBV042305411 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 | ||
| 082 | 0 | |a 572.8/633 |2 22 | |
| 245 | 1 | 0 | |a Advances in DNA sequence specific agents, Volume 3 |b a research annual |c editor Laurence H. Hurley |
| 264 | 1 | |a Greenwich (Connecticut) |b Jai Press |c 1998 | |
| 300 | |a 1 Online-Ressource (x, 283 p.) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a In this volume the entire focus is devoted to the macromolecule target specificity of DNA interactive developmental therapeutic agents of current interest. A brief introduction to DNA interactive anticancer agents is included for readers who may benefit from an overview surrounding the developments that have contributed to our general understanding of this field. The following nine chapters have been carefully chosen so that they describe topics which are at the forefront of development in DNA-targeted cancer chemotherapy. Issues that have been addressed include the mechanisms of selective DNA topoisomerase I and II poisoning by antitumor agents (Chapters 1 and 2), sequence-specific recognition of DNA by groove-binding drugs and drug-conjugates (Chapters 3 and 4), recent developments in nitrogen mustard alkylating agents and their potential use for antibody-directed enzyme-prodrug therapy (Chapter 5), nonclassical platinum anticancer complexes, including dinuclear and trans-platinum derivatives (Chapter 6), DNA cleaving antitumor chromoproteins containing reactive enediyne moieties, which exhibit interesting free-radical chemistry along with selective targeting (Chapter 7), the potential of new sequence-specific antisense and antigene therapy in oncology (Chapter 8), and finally the conceivable chemotherapeutic use of mimetics of the DNA structure, obtained by substitution of the sugar-phosphate natural chain with a peptide backbone, the so-called peptide nucleic acids (Chapter 9). Important approaches being currently investigated for selective cancer treatment, such as gene therapy and immunochemotherapy, are not discussed in this volume since they fall beyond its scope | ||
| 500 | |a Bibliogr. Index | ||
| 650 | 2 | |a ADN. | |
| 650 | 2 | |a Génétique biochimique | |
| 650 | 2 | |a Génie génétique | |
| 650 | 7 | |a Molecular biology |2 fast | |
| 650 | 7 | |a Nucleotide sequence |2 fast | |
| 650 | 4 | |a Nucleotide sequence | |
| 650 | 4 | |a Molecular biology | |
| 700 | 1 | |a Hurley, Laurence H. |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/book/9780762302031 |x Verlag |3 Volltext |
| 912 | |a ZDB-33-ESD |a ZDB-33-EBS | ||
| 940 | 1 | |q FAW_PDA_ESD | |
| 940 | 1 | |q FLA_PDA_ESD | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-027742403 | ||
Datensatz im Suchindex
| _version_ | 1804152888458477568 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV042305411 |
| collection | ZDB-33-ESD ZDB-33-EBS |
| ctrlnum | (OCoLC)162130678 (DE-599)BVBBV042305411 |
| dewey-full | 572.8/633 |
| dewey-hundreds | 500 - Natural sciences and mathematics |
| dewey-ones | 572 - Biochemistry |
| dewey-raw | 572.8/633 |
| dewey-search | 572.8/633 |
| dewey-sort | 3572.8 3633 |
| dewey-tens | 570 - Biology |
| discipline | Biologie |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03042nmm a2200433zc 4500</leader><controlfield tag="001">BV042305411</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">150129s1998 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780762302031</subfield><subfield code="9">978-0-7623-0203-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0762302038</subfield><subfield code="9">0-7623-0203-8</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)162130678</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV042305411</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">572.8/633</subfield><subfield code="2">22</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Advances in DNA sequence specific agents, Volume 3</subfield><subfield code="b">a research annual</subfield><subfield code="c">editor Laurence H. Hurley</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Greenwich (Connecticut)</subfield><subfield code="b">Jai Press</subfield><subfield code="c">1998</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (x, 283 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">In this volume the entire focus is devoted to the macromolecule target specificity of DNA interactive developmental therapeutic agents of current interest. A brief introduction to DNA interactive anticancer agents is included for readers who may benefit from an overview surrounding the developments that have contributed to our general understanding of this field. The following nine chapters have been carefully chosen so that they describe topics which are at the forefront of development in DNA-targeted cancer chemotherapy. Issues that have been addressed include the mechanisms of selective DNA topoisomerase I and II poisoning by antitumor agents (Chapters 1 and 2), sequence-specific recognition of DNA by groove-binding drugs and drug-conjugates (Chapters 3 and 4), recent developments in nitrogen mustard alkylating agents and their potential use for antibody-directed enzyme-prodrug therapy (Chapter 5), nonclassical platinum anticancer complexes, including dinuclear and trans-platinum derivatives (Chapter 6), DNA cleaving antitumor chromoproteins containing reactive enediyne moieties, which exhibit interesting free-radical chemistry along with selective targeting (Chapter 7), the potential of new sequence-specific antisense and antigene therapy in oncology (Chapter 8), and finally the conceivable chemotherapeutic use of mimetics of the DNA structure, obtained by substitution of the sugar-phosphate natural chain with a peptide backbone, the so-called peptide nucleic acids (Chapter 9). Important approaches being currently investigated for selective cancer treatment, such as gene therapy and immunochemotherapy, are not discussed in this volume since they fall beyond its scope</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Bibliogr. Index</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">ADN.</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Génétique biochimique</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Génie génétique</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Molecular biology</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nucleotide sequence</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nucleotide sequence</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Molecular biology</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hurley, Laurence H.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.sciencedirect.com/science/book/9780762302031</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-33-ESD</subfield><subfield code="a">ZDB-33-EBS</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">FAW_PDA_ESD</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">FLA_PDA_ESD</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-027742403</subfield></datafield></record></collection> |
| id | DE-604.BV042305411 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T01:17:52Z |
| institution | BVB |
| isbn | 9780762302031 0762302038 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-027742403 |
| oclc_num | 162130678 |
| open_access_boolean | |
| owner | DE-1046 |
| owner_facet | DE-1046 |
| physical | 1 Online-Ressource (x, 283 p.) |
| psigel | ZDB-33-ESD ZDB-33-EBS FAW_PDA_ESD FLA_PDA_ESD |
| publishDate | 1998 |
| publishDateSearch | 1998 |
| publishDateSort | 1998 |
| publisher | Jai Press |
| record_format | marc |
| spelling | Advances in DNA sequence specific agents, Volume 3 a research annual editor Laurence H. Hurley Greenwich (Connecticut) Jai Press 1998 1 Online-Ressource (x, 283 p.) txt rdacontent c rdamedia cr rdacarrier In this volume the entire focus is devoted to the macromolecule target specificity of DNA interactive developmental therapeutic agents of current interest. A brief introduction to DNA interactive anticancer agents is included for readers who may benefit from an overview surrounding the developments that have contributed to our general understanding of this field. The following nine chapters have been carefully chosen so that they describe topics which are at the forefront of development in DNA-targeted cancer chemotherapy. Issues that have been addressed include the mechanisms of selective DNA topoisomerase I and II poisoning by antitumor agents (Chapters 1 and 2), sequence-specific recognition of DNA by groove-binding drugs and drug-conjugates (Chapters 3 and 4), recent developments in nitrogen mustard alkylating agents and their potential use for antibody-directed enzyme-prodrug therapy (Chapter 5), nonclassical platinum anticancer complexes, including dinuclear and trans-platinum derivatives (Chapter 6), DNA cleaving antitumor chromoproteins containing reactive enediyne moieties, which exhibit interesting free-radical chemistry along with selective targeting (Chapter 7), the potential of new sequence-specific antisense and antigene therapy in oncology (Chapter 8), and finally the conceivable chemotherapeutic use of mimetics of the DNA structure, obtained by substitution of the sugar-phosphate natural chain with a peptide backbone, the so-called peptide nucleic acids (Chapter 9). Important approaches being currently investigated for selective cancer treatment, such as gene therapy and immunochemotherapy, are not discussed in this volume since they fall beyond its scope Bibliogr. Index ADN. Génétique biochimique Génie génétique Molecular biology fast Nucleotide sequence fast Nucleotide sequence Molecular biology Hurley, Laurence H. Sonstige oth http://www.sciencedirect.com/science/book/9780762302031 Verlag Volltext |
| spellingShingle | Advances in DNA sequence specific agents, Volume 3 a research annual ADN. Génétique biochimique Génie génétique Molecular biology fast Nucleotide sequence fast Nucleotide sequence Molecular biology |
| title | Advances in DNA sequence specific agents, Volume 3 a research annual |
| title_auth | Advances in DNA sequence specific agents, Volume 3 a research annual |
| title_exact_search | Advances in DNA sequence specific agents, Volume 3 a research annual |
| title_full | Advances in DNA sequence specific agents, Volume 3 a research annual editor Laurence H. Hurley |
| title_fullStr | Advances in DNA sequence specific agents, Volume 3 a research annual editor Laurence H. Hurley |
| title_full_unstemmed | Advances in DNA sequence specific agents, Volume 3 a research annual editor Laurence H. Hurley |
| title_short | Advances in DNA sequence specific agents, Volume 3 |
| title_sort | advances in dna sequence specific agents volume 3 a research annual |
| title_sub | a research annual |
| topic | ADN. Génétique biochimique Génie génétique Molecular biology fast Nucleotide sequence fast Nucleotide sequence Molecular biology |
| topic_facet | ADN. Génétique biochimique Génie génétique Molecular biology Nucleotide sequence |
| url | http://www.sciencedirect.com/science/book/9780762302031 |
| work_keys_str_mv | AT hurleylaurenceh advancesindnasequencespecificagentsvolume3aresearchannual |